GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 915 filers reported holding GLAXOSMITHKLINE PLC in Q1 2022. The put-call ratio across all filers is 0.61 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $256,000 | -97.8% | 5,870 | -97.8% | 0.00% | -100.0% |
| Q1 2022 | $11,441,000 | -80.3% | 262,657 | -80.1% | 0.02% | -85.1% |
| Q4 2021 | $58,216,000 | +87.0% | 1,320,100 | +62.0% | 0.12% | +75.4% |
| Q3 2021 | $31,137,000 | +374.2% | 814,900 | +343.0% | 0.07% | +187.5% |
| Q1 2021 | $6,566,000 | -30.5% | 183,954 | -28.3% | 0.02% | -36.8% |
| Q4 2020 | $9,445,000 | +376.1% | 256,645 | +387.0% | 0.04% | +375.0% |
| Q3 2020 | $1,984,000 | +50.9% | 52,701 | +63.5% | 0.01% | +60.0% |
| Q2 2020 | $1,315,000 | -94.0% | 32,235 | -94.5% | 0.01% | -95.3% |
| Q1 2020 | $22,025,000 | -19.7% | 581,300 | -0.4% | 0.11% | +11.6% |
| Q4 2019 | $27,424,000 | +748.8% | 583,609 | +670.9% | 0.10% | +630.8% |
| Q3 2019 | $3,231,000 | +855.9% | 75,700 | +834.6% | 0.01% | +550.0% |
| Q1 2019 | $338,000 | +9.0% | 8,100 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $310,000 | +108.1% | 8,100 | +118.9% | 0.00% | +100.0% |
| Q3 2018 | $149,000 | -81.6% | 3,700 | -81.6% | 0.00% | -80.0% |
| Q2 2018 | $810,000 | +7.4% | 20,105 | +4.1% | 0.01% | -16.7% |
| Q1 2018 | $754,000 | -56.0% | 19,304 | -52.5% | 0.01% | -62.5% |
| Q1 2017 | $1,715,000 | +72.9% | 40,676 | +76.9% | 0.02% | +23.1% |
| Q3 2016 | $992,000 | -79.8% | 23,000 | -79.7% | 0.01% | -83.1% |
| Q2 2016 | $4,919,000 | +1539.7% | 113,500 | +1433.8% | 0.08% | +1183.3% |
| Q1 2016 | $300,000 | -84.8% | 7,400 | -84.8% | 0.01% | -84.6% |
| Q4 2015 | $1,969,000 | +50.5% | 48,800 | +43.4% | 0.04% | +14.7% |
| Q3 2015 | $1,308,000 | -36.0% | 34,021 | -30.7% | 0.03% | -32.0% |
| Q2 2015 | $2,044,000 | -22.3% | 49,090 | -13.9% | 0.05% | -26.5% |
| Q1 2015 | $2,631,000 | -33.0% | 57,006 | -38.0% | 0.07% | -38.2% |
| Q4 2014 | $3,927,000 | +10.3% | 91,881 | +18.6% | 0.11% | +15.8% |
| Q3 2014 | $3,561,000 | +90.6% | 77,457 | +121.7% | 0.10% | +126.2% |
| Q2 2014 | $1,868,000 | -84.9% | 34,930 | -85.0% | 0.04% | -83.3% |
| Q1 2014 | $12,404,000 | +101.0% | 232,153 | +63.6% | 0.25% | -52.7% |
| Q4 2012 | $6,170,000 | – | 141,916 | – | 0.53% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
| KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
| Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
| Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
| CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
| PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
| Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
| Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
| EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
| Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |